Rekha Jhunjhunwala Portfolio: Multibagger Pharma Stock Zooms 17%; 207% Up In 1 Year
Wockhardt Ltd announced its financial results for FY2024-25, reporting a strong 67% year-on-year growth in EBITDA.
You may also like
